Skip to content

QTTB

Q32 Bio Inc.

NASDAQ · USHealthcareBiotechnology
$15.04-0.07%

Price as of Jul 20, 2026

QTTB capital

Q32 Bio Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.29x
Net debt / equity
-0.80x
Debt / assets
0.21x
Debt / EBITDA
0.62x
Net debt / EBITDA
-1.68x

Liquidity & coverage

Current ratio
5.36x
Quick ratio
5.36x
Cash ratio
4.76x
Interest coverage
21.41x
EBITDA / interest
22.15x
Working capital
$46.5M

Cash & dividend

FCF / debt
-2.01x
Cash flow / debt
-2.01x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.